Reliability and reproducibility of classification of children as "bleeders" versus " non-bleeders" using a questionnaire for significant mucocutaneous bleeding

被引:15
作者
Hedlund-Treutiger, I
Revel-Vilk, S
Blanchette, VS
Curtin, JA
Lillicrap, D
Rand, ML
机构
[1] Hosp Sick Children, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada
[2] Karolinska Inst, Sachs Childrens Hosp, Stockholm, Sweden
[3] Hebrew Univ Jerusalem, Hadassah Med Ctr, Pediat Hematol Oncol Unit, Jerusalem, Israel
[4] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada
[5] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[6] Childrens Hosp, Westmead, NSW, Australia
[7] Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada
[8] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada
关键词
von Willebrand disease; pediatrics; bleeding;
D O I
10.1097/01.mph.0000133600.42259.c6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The diagnosis of type I von Willebrand disease (VWD), the most common inherited bleeding disorder in humans, is greatly dependent on an accurate diagnosis of significant mucocutaneous bleeding. In a previous study, the authors modified the criteria of the International Society on Thrombosis and Haemostasis for significant mucocutaneous bleeding to a format, the Hospital for Sick Children (HSC) criteria, that was more applicable to diagnose significant mucocutaneous bleeding in children. To assess the reliability and reproducibility of classification of subjects as "bleeders" versus "nonbleeders" using a questionnaire for significant mucocutaneous bleeding targeted to children, 39 subjects interviewed for a previous HSC VWD study were reinterviewed for the current study. The original bleeding classification was confirmed in 80% of subjects interviewed for a second time, indicating that this method of classification is reproducible (K = 0.65), with a "substantial" agreement among the investigators who reviewed the questionnaire responses (K = 0.7 1). The validity and utility of the HSC questionnaire for primary screening of children with suspected mucocutaneous bleeding disorders merits assessment in further clinical studies.
引用
收藏
页码:488 / 491
页数:4
相关论文
共 12 条
[1]   The problem of diagnosing von Willebrand's disease [J].
Batlle, J ;
Torea, J ;
Rendal, E ;
Fernandez, MFL .
JOURNAL OF INTERNAL MEDICINE, 1997, 242 :121-128
[2]  
Dean JA, 2000, THROMB HAEMOSTASIS, V84, P401
[3]   Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease [J].
Favaloro, EJ .
BLOOD REVIEWS, 1999, 13 (04) :185-204
[4]   CLINICAL BIOSTATISTICS .54. THE BIOSTATISTICS OF CONCORDANCE [J].
KRAMER, MS ;
FEINSTEIN, AR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (01) :111-123
[5]   MEASUREMENT OF OBSERVER AGREEMENT FOR CATEGORICAL DATA [J].
LANDIS, JR ;
KOCH, GG .
BIOMETRICS, 1977, 33 (01) :159-174
[6]   MISINTERPRETATION AND MISUSE OF THE KAPPA-STATISTIC [J].
MACLURE, M ;
WILLETT, WC .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 126 (02) :161-169
[7]  
RODEGHIERO F, 1987, BLOOD, V69, P454
[8]  
Sadler JE, 2000, THROMB HAEMOSTASIS, V84, P160
[9]  
SADLER JE, 1994, THROMB HAEMOSTASIS, V71, P520
[10]   Von Willebrand disease type 1: a diagnosis in search of a disease [J].
Sadler, JE .
BLOOD, 2003, 101 (06) :2089-2093